Total lymphoid irradiation of SIV-infected macaques as a potential therapy for HIV infection. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Total lymphoid irradiation of SIV-infected macaques as a potential therapy for HIV infection.

Symp Nonhum Primate Models AIDS. 1993 Sep 19-22;11:abstract no. 41. Unique Identifier : AIDSLINE PRIM11/94191636
Fultz PN; Schwiebert R; Su L; Salter M; Department of Microbiology, University of Alabama at Birmingham; 35294.


Abstract: Lymph nodes appear to be reservoirs for large amounts of virus in HIV-infected persons. It is also clear that many manifestations of HIV-related disease are due to immune activation and autoimmune reactions. Total lymphoid irradiation (TLI), an effective therapy for Hodgkin's disease, has been used more recently to treat intractable rheumatoid arthritis. TLI is an immunosuppressive therapy, and after treatment, there is usually preferential repopulation of PBMC with suppressor CD8+ lymphocytes. We tested the effect of TLI on SIV infection of macaques as a method of specifically targeting cells expressing virus in lymph nodes. Two macaques with lymphadenopathy, that had been infected with SIV for 13 and 21 mos, received 3420 rad, first to the mantle and then to the inverted-Y field, in fractionated doses of 180 rad administered 5 days/wk. The animals were monitored daily for weight and clinical status; twice weekly for CBC, differential counts, and lymphocyte subsets; and every 2 wks for virologic and immunologic status. Despite severe depletion of all lymphocyte subsets, both animals remained clinically well, had no side effects, and weights were maintained at pre-TLI levels. During TLI lymphadenopathy regressed to undetectable levels, and there was no apparent increase in SIV viremia or p27 in blood, or any evidence of infection by other pathogens. After 3 months of follow-up, both animals have increased numbers of all lymphocyte subsets, with preferential repopulation of B cells and CD8+ T cells. One animal had a transient increase in the size of one axillary lymph node, while the second animal's lymphadenopathy is apparently relapsing. Semi-quantitative PCR analyses and functional studies of lymphocytes are in progress. The results to date indicate that TLI is well-tolerated in SIV-infected macaques, but long-term follow-up is required to assess potential therapeutic benefit and long-term effects on virus burden.
Keywords: Animal B-Lymphocytes/IMMUNOLOGY/RADIATION EFFECTS Human HIV Infections/IMMUNOLOGY/*RADIOTHERAPY Immunosuppression/METHODS Lymph Nodes/*RADIATION EFFECTS Lymphocyte Subsets/IMMUNOLOGY/RADIATION EFFECTS Macaca Radiotherapy/METHODS Radiotherapy Dosage Simian Acquired Immunodeficiency Syndrome/IMMUNOLOGY/ *RADIOTHERAPY SIV T-Lymphocytes/IMMUNOLOGY/RADIATION EFFECTS Time Factors ABSTRACTKWDanimalb-lymphocytes/immunology/radiationeffectshumanhivinfections/immunology/KWDradiotherapyimmunosuppression/methodslymphnodes/KWDradiationeffectslymphocytesubsets/immunology/radiationeffectsmacacaradiotherapy/methodsradiotherapydosagesimianacquiredimmunodeficiencysyndrome/immunology/KWDradiotherapysivt-lymphocytes/immunology/radiationeffectstimefactorsabstract
940730
M9470882

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .